Reel Responses, Reel Stories

reel-logo

Reel Responses, Reel Stories is a video series that explores the many dimensions of treating patients with metastatic pancreatic cancer and non–small cell lung cancer. Leading experts in the field share their triumphs and tribulations, first-hand insights on the treatment landscape, stories about caring for patients with difficult-to-treat cancers, and the role of ABRAXANE for appropriate patients. Watch the videos below, as we expose the emotional aspects of being an oncologist for both metastatic pancreatic cancer and advanced non–small cell lung cancer.

Reel Responses, Reel Stories:
Advanced Non–Small Cell Lung Cancer

Reel Responses, Reel Stories:
Metastatic Pancreatic Cancer

Reel Responses, Reel Stories

reel-logo

Reel Responses, Reel Stories is a video series that explores the many dimensions of treating patients with metastatic pancreatic cancer and non–small cell lung cancer. Leading experts in the field share their triumphs and tribulations, first-hand insights on the treatment landscape, stories about caring for patients with difficult-to-treat cancers, and the role of ABRAXANE for appropriate patients. Watch the videos below, as we expose the emotional aspects of being an oncologist for both metastatic pancreatic cancer and advanced non–small cell lung cancer.

Reel Responses, Reel Stories:
Advanced Non–Small Cell Lung Cancer

Reel Responses, Reel Stories:
Metastatic Pancreatic Cancer

INDICATIONS

ABRAXANE is indicated for:

  • The treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated
  • The first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy
  • The first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine

INDICATIONS

ABRAXANE is indicated for:

  • The treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated
  • The first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy
  • The first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine